$AROC
Archrock, Inc.

2023 Q2 Form 10-Q Financial Statement

#000138905023000022 Filed on May 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $247.5M $229.8M
YoY Change 14.69% 16.55%
Cost Of Revenue $111.4M $113.4M
YoY Change 1.19% 21.74%
Gross Profit $136.2M $116.4M
YoY Change 28.75% 11.9%
Gross Profit Margin 55.01% 50.66%
Selling, General & Admin $28.65M $26.43M
YoY Change 3.46% -4.85%
% of Gross Profit 21.04% 22.69%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $41.21M $40.18M
YoY Change -0.35% -6.64%
% of Gross Profit 30.26% 34.51%
Operating Expenses $71.32M $26.43M
YoY Change 157.56% -4.85%
Operating Profit $64.85M $90.02M
YoY Change -16.94% 18.0%
Interest Expense -$28.63M $26.58M
YoY Change -217.07% 5.29%
% of Operating Profit -44.15% 29.53%
Other Income/Expense, Net -$1.463M -$603.0K
YoY Change 194.37% 1575.0%
Pretax Income $34.58M $22.64M
YoY Change 32.69% 749.96%
Income Tax $9.931M $6.158M
% Of Pretax Income 28.72% 27.2%
Net Earnings $24.30M $16.49M
YoY Change 45.1% 857.87%
Net Earnings / Revenue 9.82% 7.17%
Basic Earnings Per Share $0.16 $0.10
Diluted Earnings Per Share $0.16 $0.10
COMMON SHARES
Basic Shares Outstanding 156.7M 156.6M
Diluted Shares Outstanding 154.4M 154.3M

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.193M $3.051M
YoY Change -38.82% 141.76%
Cash & Equivalents $1.193M $3.051M
Short-Term Investments
Other Short-Term Assets $8.571M $6.946M
YoY Change 5.48% 9.15%
Inventory $93.13M $89.63M
Prepaid Expenses
Receivables $120.7M $111.0M
Other Receivables $0.00 $0.00
Total Short-Term Assets $223.6M $210.6M
YoY Change 3.01% 7.25%
LONG-TERM ASSETS
Property, Plant & Equipment $2.316B $2.246B
YoY Change 4.71% 0.72%
Goodwill
YoY Change
Intangibles $33.32M $35.20M
YoY Change -21.03% -22.43%
Long-Term Investments
YoY Change
Other Assets $107.2M $38.31M
YoY Change 210.79% 38.09%
Total Long-Term Assets $2.456B $2.409B
YoY Change 3.03% 0.23%
TOTAL ASSETS
Total Short-Term Assets $223.6M $210.6M
Total Long-Term Assets $2.456B $2.409B
Total Assets $2.680B $2.620B
YoY Change 3.03% 0.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $65.33M $79.00M
YoY Change -16.36% 11.46%
Accrued Expenses $71.50M $92.21M
YoY Change 6.78% 2.27%
Deferred Revenue $5.261M $5.889M
YoY Change -18.5% -18.93%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $142.1M $177.1M
YoY Change -6.22% 5.22%
LONG-TERM LIABILITIES
Long-Term Debt $1.639B $1.547B
YoY Change 6.97% 1.99%
Other Long-Term Liabilities $42.06M $19.51M
YoY Change 118.45% 9.12%
Total Long-Term Liabilities $1.681B $1.567B
YoY Change 8.35% 2.08%
TOTAL LIABILITIES
Total Short-Term Liabilities $142.1M $177.1M
Total Long-Term Liabilities $1.681B $1.567B
Total Liabilities $1.824B $1.767B
YoY Change 5.62% 2.27%
SHAREHOLDERS EQUITY
Retained Earnings -$2.515B -$2.517B
YoY Change 1.03% 1.31%
Common Stock $1.649M $1.649M
YoY Change 0.98% 1.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $855.5M $853.1M
YoY Change
Total Liabilities & Shareholders Equity $2.680B $2.620B
YoY Change 3.03% 0.76%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $24.30M $16.49M
YoY Change 45.1% 857.87%
Depreciation, Depletion And Amortization $41.21M $40.18M
YoY Change -0.35% -6.64%
Cash From Operating Activities $30.54M $87.86M
YoY Change 135.81% 14.74%
INVESTING ACTIVITIES
Capital Expenditures $103.1M $84.39M
YoY Change -268.42% -288.13%
Acquisitions
YoY Change
Other Investing Activities $9.804M $26.73M
YoY Change -81.09% 225.93%
Cash From Investing Activities -$93.28M -$57.67M
YoY Change 894.88% 57.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $160.1M
YoY Change -14.16%
Cash From Financing Activities 60.88M -28.71M
YoY Change -2208.03% -28.63%
NET CHANGE
Cash From Operating Activities 30.54M 87.86M
Cash From Investing Activities -93.28M -57.67M
Cash From Financing Activities 60.88M -28.71M
Net Change In Cash -1.858M 1.485M
YoY Change -370.06% -583.71%
FREE CASH FLOW
Cash From Operating Activities $30.54M $87.86M
Capital Expenditures $103.1M $84.39M
Free Cash Flow -$72.54M $3.464M
YoY Change -197.82% -97.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
8280000
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
8586000
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001389050
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P9M
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-33666
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Archrock, Inc.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
74-3204509
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
9807 Katy Freeway
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Houston
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77024
CY2023Q1 dei City Area Code
CityAreaCode
281
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
836-8000
CY2023Q1 dei Security12b Title
Security12bTitle
Common stock, $0.01 par value per share
CY2023Q1 dei Trading Symbol
TradingSymbol
AROC
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
156695322
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3051000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1566000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1318000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1674000
CY2023Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
110994000
CY2022Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
137544000
CY2023Q1 us-gaap Inventory Net
InventoryNet
89632000
CY2022Q4 us-gaap Inventory Net
InventoryNet
84622000
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
6946000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
8228000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
210623000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
231960000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2246245000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2199253000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16111000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16706000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
35196000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
37077000
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
35998000
CY2022Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
34736000
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
29146000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
33353000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
38307000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
37079000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
229834000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
197201000
CY2023Q1 us-gaap Assets
Assets
2619906000
CY2022Q4 us-gaap Assets
Assets
2598750000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
78999000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
64324000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
92213000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
76915000
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5889000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7332000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
177101000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
148571000
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1547274000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1548334000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14170000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14861000
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
934000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
854000
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
19509000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
17569000
CY2023Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
7868000
CY2022Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
7868000
CY2023Q1 us-gaap Liabilities
Liabilities
1766856000
CY2022Q4 us-gaap Liabilities
Liabilities
1738057000
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
164903900
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
163439013
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
1649000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1634000
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3460259000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3456777000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2516500000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2509133000
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
8207390
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
7810548
CY2023Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
92358000
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
88585000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
853050000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
860693000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2619906000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2598750000
CY2023Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
113390000
CY2022Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
93139000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
26425000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
27773000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
40181000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
43039000
CY2023Q1 aroc Long Lived And Other Asset Impairment
LongLivedAndOtherAssetImpairment
2569000
CY2022Q1 aroc Long Lived And Other Asset Impairment
LongLivedAndOtherAssetImpairment
7416000
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
1047000
CY2023Q1 us-gaap Interest Expense
InterestExpense
26581000
CY2022Q1 us-gaap Interest Expense
InterestExpense
25246000
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
3605000
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
2112000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-603000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-36000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
22643000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2664000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6158000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
943000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
16485000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
1721000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
154116000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
152690000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
154281000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
152810000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
16485000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
1721000
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
574000
CY2022Q1 aroc Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Adjustments On Dedesignation After Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsOnDedesignationAfterTax
-410000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
984000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
16485000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2705000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
891438000
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2363000
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.145
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
22673000
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
149000
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3067000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
1721000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
984000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
872323000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
860693000
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
3773000
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
23852000
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
170000
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3327000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
16485000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
853050000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
16485000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
1721000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
40181000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
43039000
CY2023Q1 aroc Long Lived And Other Asset Impairment
LongLivedAndOtherAssetImpairment
2569000
CY2022Q1 aroc Long Lived And Other Asset Impairment
LongLivedAndOtherAssetImpairment
7416000
CY2023Q1 us-gaap Restructuring Reserve Settled Without Cash2
RestructuringReserveSettledWithoutCash2
927000
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-254000
CY2023Q1 us-gaap Inventory Write Down
InventoryWriteDown
216000
CY2022Q1 us-gaap Inventory Write Down
InventoryWriteDown
294000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
823000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
780000
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1288000
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1288000
CY2023Q1 aroc Amortization Of Debt Premium
AmortizationOfDebtPremium
501000
CY2022Q1 aroc Amortization Of Debt Premium
AmortizationOfDebtPremium
502000
CY2023Q1 aroc Amortization Of Capitalized Implementation Costs
AmortizationOfCapitalizedImplementationCosts
597000
CY2022Q1 aroc Amortization Of Dedesignated Interest Rate Swaps
AmortizationOfDedesignatedInterestRateSwaps
410000
CY2022Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-631000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3327000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3067000
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-340000
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
108000
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
3605000
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
2112000
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
5881000
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
886000
CY2023Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
5090000
CY2022Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
4476000
CY2023Q1 aroc Contract With Customer Liability Revenue Recognized From Beginning Balance And Current Period
ContractWithCustomerLiabilityRevenueRecognizedFromBeginningBalanceAndCurrentPeriod
4476000
CY2022Q1 aroc Contract With Customer Liability Revenue Recognized From Beginning Balance And Current Period
ContractWithCustomerLiabilityRevenueRecognizedFromBeginningBalanceAndCurrentPeriod
3115000
CY2023Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-7632000
CY2022Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
15084000
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4131000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1021000
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-609000
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-444000
CY2023Q1 aroc Increase Decrease Capitalized Contract Cost
IncreaseDecreaseCapitalizedContractCost
6352000
CY2022Q1 aroc Increase Decrease Capitalized Contract Cost
IncreaseDecreaseCapitalizedContractCost
5320000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
18219000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
32718000
CY2023Q1 aroc Increase Decrease In Contract With Customer Liability Excluding Revenue Recognized From Beginning Balance And Current Period
IncreaseDecreaseInContractWithCustomerLiabilityExcludingRevenueRecognizedFromBeginningBalanceAndCurrentPeriod
3179000
CY2022Q1 aroc Increase Decrease In Contract With Customer Liability Excluding Revenue Recognized From Beginning Balance And Current Period
IncreaseDecreaseInContractWithCustomerLiabilityExcludingRevenueRecognizedFromBeginningBalanceAndCurrentPeriod
6351000
CY2023Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
16000
CY2022Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-97000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
87856000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
76572000
CY2023Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
84392000
CY2022Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
44858000
CY2023Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
28726000
CY2022Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
5437000
CY2022Q1 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
2763000
CY2023Q1 us-gaap Payments To Acquire Equity Securities Fv Ni
PaymentsToAcquireEquitySecuritiesFvNi
2000000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-57666000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-36658000
CY2023Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
158850000
CY2022Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
172500000
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
160100000
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
186500000
CY2022Q1 us-gaap Payments For Proceeds From Hedge Financing Activities
PaymentsForProceedsFromHedgeFinancingActivities
1334000
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
23852000
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
22673000
CY2023Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
170000
CY2022Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
149000
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3773000
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2363000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-28705000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-40221000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1485000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-307000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1566000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1569000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3051000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1262000
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2022Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
22494000
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.145
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
22673000
CY2023Q1 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
73573000
CY2022Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
70228000
CY2023Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
16059000
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
14394000
CY2023Q1 us-gaap Inventory Net
InventoryNet
89632000
CY2022Q4 us-gaap Inventory Net
InventoryNet
84622000
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3519866000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3454843000
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1273621000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1255590000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2246245000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2199253000
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1547274000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1548334000
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.150
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
23852000
CY2022Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.145
CY2022Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
22589000
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.145
CY2022Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
22559000
CY2022Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.145
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
229834000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
197201000
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
354700000
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
203117000
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
88750000
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
47044000
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
11658000
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
3608000
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
504000
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
354681000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1674000
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-340000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
16000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1318000
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
6800000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
8000000.0
CY2023Q1 aroc Increase Decrease In Contract With Customer Liability Excluding Revenue Recognized From Beginning Balance And Current Period
IncreaseDecreaseInContractWithCustomerLiabilityExcludingRevenueRecognizedFromBeginningBalanceAndCurrentPeriod
3200000
CY2023Q1 aroc Contract With Customer Liability Revenue Recognized From Beginning Balance And Current Period
ContractWithCustomerLiabilityRevenueRecognizedFromBeginningBalanceAndCurrentPeriod
4500000
CY2023Q1 us-gaap Restructuring And Related Cost Expected Cost Remaining1
RestructuringAndRelatedCostExpectedCostRemaining1
1500000
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
1047000
CY2023Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
120000
CY2023Q1 us-gaap Restructuring Reserve
RestructuringReserve
927000
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
1047000
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
1047000
CY2023Q1 us-gaap Decrease In Unrecognized Tax Benefits Is Reasonably Possible
DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
2700000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
16485000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
1721000
CY2023Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
735000
CY2022Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
515000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
15750000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
15750000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1206000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
1206000
CY2023Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
154116000
CY2022Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
152690000
CY2023Q1 aroc Incremental Common Shares Attributable To Dilutive Effect Of Restricted Stock
IncrementalCommonSharesAttributableToDilutiveEffectOfRestrictedStock
162000
CY2022Q1 aroc Incremental Common Shares Attributable To Dilutive Effect Of Restricted Stock
IncrementalCommonSharesAttributableToDilutiveEffectOfRestrictedStock
117000
CY2023Q1 aroc Incremental Common Shares Attributable To Dilutive Effect Of Employee Stock Purchase Plan
IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan
3000
CY2022Q1 aroc Incremental Common Shares Attributable To Dilutive Effect Of Employee Stock Purchase Plan
IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan
3000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
154281000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
152810000
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
229834000
CY2023Q1 aroc Gross Margin
GrossMargin
116444000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
197201000
CY2022Q1 aroc Gross Margin
GrossMargin
104062000
CY2023Q1 aroc Gross Margin
GrossMargin
116444000
CY2022Q1 aroc Gross Margin
GrossMargin
104062000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
26425000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
27773000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
40181000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
43039000
CY2023Q1 aroc Long Lived And Other Asset Impairment
LongLivedAndOtherAssetImpairment
2569000
CY2022Q1 aroc Long Lived And Other Asset Impairment
LongLivedAndOtherAssetImpairment
7416000
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
1047000
CY2023Q1 us-gaap Interest Expense
InterestExpense
26581000
CY2022Q1 us-gaap Interest Expense
InterestExpense
25246000
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
3605000
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
2112000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-603000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-36000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
22643000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2664000

Files In Submission

Name View Source Status
aroc-20230331_cal.xml Edgar Link unprocessable
0001389050-23-000022-index-headers.html Edgar Link pending
0001389050-23-000022-index.html Edgar Link pending
0001389050-23-000022.txt Edgar Link pending
0001389050-23-000022-xbrl.zip Edgar Link pending
aroc-20230331.xsd Edgar Link pending
aroc-20230331x10q.htm Edgar Link pending
aroc-20230331xex31d1.htm Edgar Link pending
aroc-20230331xex31d2.htm Edgar Link pending
aroc-20230331xex32d1.htm Edgar Link pending
aroc-20230331xex32d2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
aroc-20230331_def.xml Edgar Link unprocessable
aroc-20230331_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
aroc-20230331_pre.xml Edgar Link unprocessable
aroc-20230331x10q_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending